ShareValue.ai

ShareValue scores for ACL.AU: Valuation 57, Quality 79, Growth 36, Health 46.

Australian Clinical Labs Ltd logo

ACL.AU
ASX

Australian Clinical Labs Ltd

A$2.23(-2.19%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 15%
Valuation
57
Fair Value
Price vs Value
Quality
79
Strong
Business Strength
Growth
36
Weak
Revenue & Earnings
Health
46
Moderate
Financial Stability
Momentum
83
Bullish
Price Trend

Company Details

About

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Score Analysis

AI Investment Thesis

Data as of:Jul 7, 2026
|
Last calculated:Jul 8, 2026